AscentX Medical
La Jolla, US · Founded 2017 · Delaware corporation
AscentX Medical develops injectable regenerative therapy using autologous tissue engineering with microspheres to restore soft tissue function, targeting the aging population and patients in clinical settings. The company is also launching cGMP aseptic fill and finish contract manufacturing (CMO) services for the pharmaceutical and medical device industries.
Founders & leadership
AscentX Medical was founded in 2017 by Larry J. Braga.
LJ
Larry J. BragainFounder
GL
Gottfried LemperleNamed on SEC filing
SL
Stefan LemperleNamed on SEC filing
Board
GL
Glen LehmanBoard director
JS
John StiskaBoard director
YW
Yibo WangBoard director
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 4 rounds · 2018–2023
▶$1.1MraisedNov 2023 · 40 investors · Other Health CareRule 506(b)
▶$1.1MraisedNov 2023 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John LynchDirector
- David FrisciaDirector
- Yibo WangDirector
- Gottfried LemperleDirector
- Juergen SiemonsmeirDirector
- Larry BragaExecutive Officer, Director
- John StiskaDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedAug 2021 · 46 investors · Other Health CareRule 506(b)
▶$3.7MraisedAug 2021 · 46 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Glen LehmanDirector
- Gottfried LemperleDirector
- John StiskaDirector
- Yibo WangDirector
- Stefan LemperleExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $3.7M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$325KraisedApr 2019 · 5 investors · OtherRule 506(b)
▶$325KraisedApr 2019 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gottfried LemperleDirector
- Stefan LemperleExecutive Officer, Director
- Glen LehmanDirector
- John StiskaDirector
- Yibo WangDirector
- Offering amount
- $800K
- Amount sold
- $325K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.2MraisedApr 2018 · 27 investors · OtherRule 506(b)
▶$1.2MraisedApr 2018 · 27 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Glen LehmanDirector
- John StiskaDirector
- Yibo WangDirector
- Gottfried LemperleDirector
- Stefan LemperleExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $1.2M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with AscentX Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AscentX Medical do?
- AscentX Medical develops injectable regenerative therapy using autologous tissue engineering with microspheres to restore soft tissue function, targeting the aging population and patients in clinical settings. The company is also launching cGMP aseptic fill and finish contract manufacturing (CMO) services for the pharmaceutical and medical device industries.
- Who founded AscentX Medical?
- AscentX Medical was founded by Larry J. Braga in 2017.
- How much funding has AscentX Medical raised?
- AscentX Medical has disclosed $6.4M raised across 4 rounds.
- Where is AscentX Medical headquartered?
- AscentX Medical is headquartered in La Jolla, US.